Effects of methylene blue on propofol requirement during anaesthesia induction and surgery

Anaesthesia

Volumn 63, Issue 4, 2008, Pages 352-357

  Licker, M ^a   Diaper, J ^a   Robert, J ^a   Ellenberger, C ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; PROPOFOL;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BISPECTRAL INDEX; CLINICAL ARTICLE; DRUG INFUSION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MALE; PARATHYROIDECTOMY; SEDATION;

AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; CASE-CONTROL STUDIES; COLORING AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; PARATHYROIDECTOMY; PROPOFOL;

EID: 40549126351     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05354.x     Document Type: Article

References (39)

1. Clifton J 2nd, Leikin JB. Methylene blue. American Journal of Therapeutics 2003 10 : 289 91.
2. Patel PN. Methylene blue for management of Ifosfamide-induced encephalopathy. Annals of Pharmacotherapy 2006 40 : 299 303.
3. Dudley NE. Methylene blue for rapid identification of the parathyroids. British Medical Journal 1971 3 : 680 1.
4. Robert J, Delay D, Buhler L, Garcia A, Spilipoulos A. [Methylene blue in surgery of primary hyperparathyroidism]. Annales D'endocrinologie (Paris) 1998 59 : 23 6.
5. Wheeler MH, Wade JS. Intraoperative identification of parathyroid glands: appraisal of methylene blue staining. American Journal of Surgery 1982 143 : 713 6.
6. Kwok ES, Howes D. Use of methylene blue in sepsis: a systematic review. Journal of Intensive Care Medicine 2006 21 : 359 63.
7. Faber P, Ronald A, Millar BW. Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass. Anaesthesia 2005 60 : 575 87.
8. Shanmugam G. Vasoplegic syndrome: the role of methylene blue. European Journal of Cardiothoracic Surgery 2005 28 : 705 10.
9. Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesthesia and Analgesia 2002 94 : 824 9.
10. Kartha SS, Chacko CE, Bumpous JM, Fleming M, Lentsch EJ, Flynn MB. Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngology, Head and Neck Surgery 2006 135 : 765 8.
11. Bach KK, Lindsay FW, Berg LS, Howard RS. Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesthesia and Analgesia 2004 99 : 1573 4.
12. Mathew S, Linhartova L, Raghuraman G. Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy. Anaesthesia 2006 61 : 580 3.
13. Sweet G, Standiford SB. Methylene-blue-associated encephalopathy. Journal of the American College of Surgery 2007 204 : 454 8.
14. Khan MA, North AP, Chadwick DR. Prolonged postoperative altered mental status after methylene blue infusion during parathyroidectomy: a case report and review of the literature. Annals of the Royal College of Surgeons of England 2007 89 : W9 11.
15. Martindale SJ, Stedeford JC. Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia 2003 58 : 1041 2.
16. Siebert C, Kroeber S, Lutter N. Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesthesia and Analgesia 2005 101 : 608 9.
17. Mihai R, Mitchell EW, Warwick J. Dose-response and postoperative confusion following methylene blue infusion during parathyroidectomy. Canadian Journal of Anaesthesia 2007 54 : 79 81.
18. Majithia A, Stearns MP. Methylene blue toxicity following infusion to localize parathyroid adenoma. Journal of Laryngology and Otology 2006 120 : 138 40.
19. Struys MM, De Smet T, Depoorter B, et al. Comparison of plasma compartment versus two methods for effect compartment - controlled target-controlled infusion for propofol. Anesthesiology 2000 92 : 399 406.
20. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999 90 : 1502 16.
21. Gale T, Leslie K, Kluger M. Propofol anaesthesia via target controlled infusion or manually controlled infusion: effects on the bispectral index as a measure of anaesthetic depth. Anaesthesia and Intensive Care 2001 29 : 579 84.
22. Irwin MG, Hui TW, Milne SE, Kenny GN. Propofol effective concentration 50 and its relationship to bispectral index. Anaesthesia 2002 57 : 242 8.
23. Milne SE, Troy A, Irwin MG, Kenny GN. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. British Journal of Anaesthesia 2003 90 : 127 31.
24. Gurses E, Sungurtekin H, Tomatir E, Dogan H. Assessing propofol induction of anesthesia dose using bispectral index analysis. Anesthesia and Analgesia 2004 98 : 128 31.
25. Barakat AR, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia 2007 62 : 661 6.
26. Kim DW, Kil HY, White PF. Relationship between clinical endpoints for induction of anesthesia and bispectral index and effect-site concentration values. Journal of Clinical Anesthesia 2002 14 : 241 5.
27. Singh H. Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia. European Journal of Anaesthesiology 1999 16 : 31 6.
28. Struys M, Versichelen L, Byttebier G, Mortier E, Moerman A, Rolly G. Clinical usefulness of the bispectral index for titrating propofol target effect-site concentration. Anaesthesia 1998 53 : 4 12.
29. Peter C, Hongwan D, Kupfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. European Journal of Clinical Pharmacology 2000 56 : 247 50.
30. Miyawaki I, Nakamura K, Yokubol B, Kitamura R, Mori K. Suppression of cyclic guanosine monophosphate formation in rat cerebellar slices by propofol, ketamine and midazolam. Canadian Journal of Anaesthesia 1997 44 : 1301 7.
31. Masaki E, Kondo I. Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats. Anesthesia and Analgesia 1999 89 : 484 9.
32. Engelhardt T, Lowe PR, Galley HF, Webster NR. Inhibition of neuronal nitric oxide synthase reduces the propofol requirements in wild-type and nNOS knockout mice. European Journal of Anaesthesiology 2006 23 : 197 201.
33. Cockcroft JR. Exploring vascular benefits of endothelium-derived nitric oxide. American Journal of Hypertension 2005 18 (12, Part 2 177S 183S.
34. Evgenov OV, Sveinbjornsson B, Bjertnaes LJ. Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep. Acta Anaesthesiologica Scandinavica 2001 45 : 1246 54.
35. Menardi AC, Viaro F, Vicente WV, Rodrigues AJ, Evora PR. Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue. Arquivos Brasileiros de Cardiologia 2006 87 : 525 32.
36. Iwamoto ET, Marion L. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. Journal of Pharmacology and Experimental Therapeutics 1994 269 : 699 708.
37. Soares-da-Silva P, Caramona MM. Effects of methylene blue on the uptake, release and metabolism of noradrenaline in mesenteric arterial vessels. Journal of Pharmacy and Pharmacology 1988 40 : 534 8.
38. Cermik TF, Kaya M, Ugur-Altun B, Bedel D, Berkarda S, Yigitbasi ON. Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism. Neuroradiology 2007 49 : 379 85.
39. Perrier ND, Coker LH, Rorie KD, et al. Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World Journal of Surgery 2006 30 : 686 96.